{"id":156442,"date":"2026-08-20T09:52:24","date_gmt":"2026-08-20T09:52:24","guid":{"rendered":"https:\/\/www.europesays.com\/sk\/156442\/"},"modified":"2026-08-20T09:52:24","modified_gmt":"2026-08-20T09:52:24","slug":"sukl-z-trhu-stahuje-dva-dolezite-lieky-pri-vyrobe-urobili-chybu-nemate-ich-doma","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/sk\/156442\/","title":{"rendered":"\u0160\u00daKL z trhu s\u0165ahuje dva d\u00f4le\u017eit\u00e9 lieky, pri v\u00fdrobe urobili chybu. Nem\u00e1te ich doma?"},"content":{"rendered":"

\t\t\t\t\t\t\t\"Ilustra\u010dn\u00e9<\/p>\n

\t\t\t\t\tIlustra\u010dn\u00e9 foto. ZDROJ: pixabay.com<\/p>\n

\t\t<\/p>\n

\u0160t\u00e1tny \u00fastav pre kontrolu lie\u010div (\u0160\u00daKL) s\u0165ahuje v priebehu p\u00e1r dn\u00ed z trhu dva nevyhovuj\u00face lieky. Ur\u010den\u00e9 s\u00fa na lie\u010dbu mo\u010dov\u00fdch a obli\u010dkov\u00fdch kame\u0148ov a na lie\u010dbu skler\u00f3zy. <\/p>\n

\u0160\u00daKL v utorok (18.8.) informoval<\/a> o stiahnut\u00ed dvoch \u0161ar\u017e\u00ed lieku Rowatinex, gtt por 1\u00d710 ml, z trhu. D\u00f4vodom stiahnutia je nedostatok v kvalite lieku.<\/p>\n

Opatrenie sa t\u00fdka \u0161ar\u017ee 8706L s exspir\u00e1ciou v apr\u00edli 2027 a \u0161ar\u017ee 8768L s exspir\u00e1ciou v septembri 2027. Stiahnutie prebieha na \u00farovni distribu\u010dn\u00fdch spolo\u010dnost\u00ed, lek\u00e1rn\u00ed a zdravotn\u00edckych zariaden\u00ed.<\/p>\n

Mohlo by v\u00e1s zauj\u00edma\u0165:<\/p>\n

Reklama<\/p>\n

div {
\ntext-align: left;
\nfont-size: 12px;
\ncolor: #6f6f6f;
\n}<\/p>\n

#onnetwork-banner > div:first-child {
\ntext-align: left;
\nfont-weight: 700;
\npadding-bottom: 5px;
\nfont-size: 14px;
\ncolor: #000000;
\n}<\/p>\n

]]><\/p>\n

\u0160\u00daKL ako d\u00f4vod uv\u00e1dza nedostatok v kvalite lieku. Pri kontrole zaznamenali v\u00fdsledok mimo stanoven\u00e9ho limitu v parametri peroxidov\u00e9 \u010d\u00edslo.<\/p>\n

Na \u010do sl\u00fa\u017ei liek? Rowatinex pom\u00e1ha pri mo\u010dov\u00fdch a obli\u010dkov\u00fdch kame\u0148och. Obsahuje zmes terp\u00e9nov, ktor\u00e9 podporuj\u00fa rozpad, rozpustenie a vyplavovanie mo\u010dov\u00fdch a obli\u010dkov\u00fdch kame\u0148ov. Liek z\u00e1rove\u0148 uvo\u013e\u0148uje k\u0155\u010de mo\u010dov\u00fdch ciest a u\u013eah\u010duje prechod kame\u0148ov mo\u010dov\u00fdm traktom. Pou\u017e\u00edva sa pri lie\u010dbe uroliti\u00e1zy a nefroliti\u00e1zy, na zmiernenie sprievodn\u00fdch pr\u00edznakov aj na podporu odstr\u00e1nenia zvy\u0161kov kame\u0148ov po litotrypsii.<\/p>\n

S\u0165ahuj\u00fa aj liek na lie\u010dbu skler\u00f3zy <\/p>\n

\u0160\u00daKL z trhu s\u0165ahuje<\/a> aj liek\u00a0Fingolimod\u00a0Zentiva\u00a00,5 mg,\u00a0\u0160\u00daKL k\u00f3d:\u00a06403D. \u202fStiahnutie lieku\u00a0z trhu sa t\u00fdka \u0161ar\u017ee s \u010d\u00edslom\u00a0\u202f4L01372P\u00a0s d\u00e1tumom exspir\u00e1cie\u00a0november 2027.\u00a0Aj tento liek sa s\u0165ahuje z \u00farovne distribu\u010dn\u00fdch\u00a0spolo\u010dnost\u00ed,\u00a0lek\u00e1rn\u00ed\u00a0a zdravotn\u00edckych zariaden\u00ed.\u00a0<\/p>\n

\u201eD\u00f4vodom stiahnutia\u00a0dotknutej \u0161ar\u017ee\u00a0lieku\u202f\u202fFingolimod\u00a0Zentiva\u00a00,5 mg,\u00a0cps\u00a0dur 28\u00d70,5 mg\u00a0jenes\u00falad\u00a0s po\u017eiadavkami spr\u00e1vnej v\u00fdrobnej praxe.\u00a0Stiahnutie z\u202ftrhu m\u00e1 prevent\u00edvny charakter v\u202fz\u00e1ujme ochrany zdravia pacientov,\u201c pribl\u00ed\u017eil \u0160\u00daKL. <\/p>\n

Na \u010do sl\u00fa\u017ei liek? Pou\u017e\u00edva\u00a0sa\u00a0na lie\u010dbu vysoko akt\u00edvnej relaps-remituj\u00facej roztr\u00fasenej skler\u00f3zy (skler\u00f3zy\u00a0multiplex) u dospel\u00fdch a det\u00ed\u00a0vo veku 10 rokov a star\u0161\u00edch s hmotnos\u0165ou nad 40 kg.\u00a0Obsahuje lie\u010divo\u00a0fingolimod, ktor\u00e9 patr\u00ed do\u00a0farmakoterapeutickej\u00a0skupiny \u2013 selekt\u00edvne\u00a0imunosupres\u00edva. <\/p>\n

Pod\u013ea \u0160\u00daKL lie\u010dba pacientov nie je ohrozen\u00e1. Na slovenskom trhu s\u00fa dostupn\u00e9 in\u00e9 liekov\u00e9 formy rovnak\u00fdmi terapeutick\u00fdmi indik\u00e1ciami. Pacienti sa o vhodnej lie\u010dbe m\u00f4\u017eu poradi\u0165 s lek\u00e1rnikom alebo o\u0161etruj\u00facim lek\u00e1rom.<\/p>\n

\t\t
\n\t\t\t\"Ve\u013ek\u00fd
\n\t\t<\/a><\/p>\n

Pre\u010d\u00edtajte si tie\u017e<\/p>\n

\t\t\tVe\u013ek\u00fd re\u0165azec pred\u00e1val nebezpe\u010dn\u00fd v\u00fdrobok: V obchodoch bol 1,5 roka, hrozia smrte\u013en\u00e9 n\u00e1sledky<\/a><\/p>\n

Viac o t\u00e9me: liek<\/a>, stiahnutie<\/a>, \u0160\u00daKL<\/a><\/p>\n

\t\tKoment\u00e1re k \u010dl\u00e1nku<\/p>\n

Moment\u00e1lne nie je pridan\u00fd \u017eiadny koment\u00e1r<\/p>\n","protected":false},"excerpt":{"rendered":"Ilustra\u010dn\u00e9 foto. ZDROJ: pixabay.com \u0160t\u00e1tny \u00fastav pre kontrolu lie\u010div (\u0160\u00daKL) s\u0165ahuje v priebehu p\u00e1r dn\u00ed z trhu dva…\n","protected":false},"author":2,"featured_media":156443,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[32],"tags":[34,37,3500,33,43,40,39,42,41,36,21356,1029,38,35],"class_list":["post-156442","post","type-post","status-publish","format-standard","has-post-thumbnail","category-spravy","tag-headlines","tag-hlavne-spravy","tag-liek","tag-news","tag-sk","tag-slovak","tag-slovakia","tag-slovencina","tag-slovensko","tag-spravy","tag-stiahnutie","tag-sukl","tag-titulky","tag-top-stories"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@sk\/117127226974284780","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/posts\/156442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/comments?post=156442"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/posts\/156442\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/media\/156443"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/media?parent=156442"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/categories?post=156442"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/tags?post=156442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}